CareTrust REIT Raises 2026 Guidance After Record Q2, $1.5B Deployed YTD
CTRE sits 29% above its 52-week low of $31.92.
Summary
CareTrust REIT reported Q2 2026 results with Normalized FFO of $0.51 per share, up 19% year-over-year, and raised full-year guidance. The new Normalized FFO midpoint of $2.045 implies 16.2% growth over 2025. The company deployed $899.6 million in Q2 at an 8.9% yield, bringing year-to-date investments to roughly $1.5 billion. Liquidity remains robust with $605 million available on its revolver and $671 million in unsettled forward equity proceeds. The raised guidance and strong investment pace signal continued external growth momentum. The conference call tomorrow morning may provide additional color on the $540 million pipeline and capital deployment plans.
At the time of this announcement, CTRE was trading at $41.13 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $9.7B. The 52-week trading range was $31.92 to $43.62. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.